Clinical Trial Update: Escitalopram in Schizophrenia in OCD- Open Label Study [Phase 4]

View source ↗

Summary

Open-label Phase 4 trial evaluating escitalopram in schizophrenia with comorbid obsessive-compulsive disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obsessive-compulsive Disorder
• Schizophrenia

Drugs mentioned

• Escitalopram (escitalopram)

Snippet

Sponsor: BeerYaakov Mental Health Center | Conditions: Schizophrenia | Phase 4 | Status: COMPLETED